Next Quarterly Earnings
After-hours — typically from around 10:00 p.m. German time (after the US close at 4:00 p.m. New York time).
AbCellera Biologics is a leading biotechnology company revolutionizing antibody discovery. It leverages an AI-driven platform and machine learning to significantly accelerate the development of novel therapeutic antibodies. The company offers innovative solutions to partners in pharmaceutical research for effective drug development.
After-hours — typically from around 10:00 p.m. German time (after the US close at 4:00 p.m. New York time).
AbCellera Biologics is scheduled to report its next quarterly earnings on 11/10/2026. After-hours — typically from around 10:00 p.m. German time (after the US close at 4:00 p.m. New York time).
AbCellera Biologics last reported quarterly earnings on 8/5/2026 (Q2 2026). Earnings per share (EPS) came in at -0.18 USD.
Across its last 3 earnings reports, AbCellera Biologics stock moved by ±6.8% on average the following day. The largest reaction was -13.7% on 11/06/2025; 0 of 3 reactions were positive.
AbCellera Biologics has beaten analyst EPS estimates in 3 of its last 5 evaluated quarters (beat rate: 60%).
Use the 'Subscribe in calendar' button on this page to add all dates to Google Calendar, Apple Calendar or Outlook. Dates update automatically when they change.
Basis: price reactions to the last 3 report dates (close to close).
Basis: 5 quarters with an analyst estimate and reported EPS.
Past price reactions are not a reliable indicator of future performance.